http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017217444-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34 |
filingDate | 2017-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2017217444-A1 |
titleOfInvention | Method for processing double-stranded DNA ends |
abstract | The method for preparing DNA includes (i) Moloney murine leukemia virus reverse transcriptase consisting of the amino acid sequence represented by SEQ ID NO: 1, and (ii) substitution of one or more amino acids in the amino acid sequence represented by SEQ ID NO: 1, (Iii) a protein consisting of an amino acid sequence having 90% or more identity with the amino acid sequence represented by SEQ ID NO: 1, or iv) using a protein consisting of an amino acid sequence represented by SEQ ID NO: 1 (SEQ ID NO: 1) having an identity of 40% or more and having the effect of adding a base to double-stranded DNA; Adding one of the following bases (1) to (6) to the 3 ′ end of one or both strands of DNA. (1) 1, 2, 3, or 4 consecutive adenines (A) (2) 1-20 consecutive cytosines (C) (3) 1-20 consecutive guanines (G) (4) 1, 2, 3, or 4 consecutive thymines (T) (5) 2 to 20 consecutive bases comprising adenine (A), cytosine (C), guanine (G ) Or a combination of two or more of thymine (T) (6) the modified base of any one of (1) to (5) |
priorityDate | 2016-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 145.